TF Securities(SH:601162) Xin Lang Cai Jing·2025-09-09 13:33Core Insights - Jiangsu Aipeng Medical Technology Co., Ltd. conducted a specific investor survey with 28 institutions, discussing business layout and new product competitiveness [1] Business Layout and Product Development - Aipeng Medical focuses on medical devices, particularly in acute and chronic pain management and nasal cavity management, while actively exploring innovations in brain-computer interface technology [2] - The company is developing applications in brain-computer interfaces, including perioperative brain state monitoring and treatment systems for insomnia and ADHD [2] ADHD Product Competitiveness and Collaboration - Aipeng Medical recently obtained two registration certificates for its "Multimodal ADHD Behavioral Treatment System," which integrates data connectivity from in-hospital training centers to home training scenarios, involving parents in the treatment process [3] - The treatment cost for each child ranges from 10,000 to 25,000 yuan, depending on the severity of the condition, with a long treatment cycle requiring both medication and behavioral interventions [3] - The effectiveness of behavioral therapy is enhanced with higher training frequency, typically showing results within 3 to 6 months [3] Market Expansion and Challenges - The company has experience in serious medical fields, which aids in replicating new product business models, with plans to collaborate with training institutions and private hospitals for product distribution [4] - The pain management business is currently facing challenges due to policy changes and price reductions, leading to a decline in sales, although there was a recovery in the second quarter compared to the first [4] - The nasal care business is experiencing growth in market demand but faces intense competition from counterfeit products, prompting the company to leverage brand differentiation and optimize retail and clinical sales [4]